Stock Taper 
EOCN
$3.37
▼ DOWN 3.16% (-0.11)
KEY STATISTICS
Market Cap$3.51 M
52w High$13.20
52w Low$3.27
Dividend Yield—
Frequency—
P/E-0.24
Volume8.49K
Shares Out.1.04M
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
Allen J. Baharaff
ABOUT
SECTOR
Healthcare
WENT PUBLIC
September 10, 2026
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
6
PRICE
$3.37 ▼ DOWN 3.16% (−$0.11)About Eocene Ltd.
http://galmedpharma.com ↗Eocene Ltd. is a Tel Aviv-based clinical-stage biopharmaceutical company developing Aramchol, an oral therapy for NASH in overweight or obese patients with prediabetes or type II diabetes.
INDUSTRY
Medical - Pharmaceuticals
A PRODUCT EOCENE LTD. IS KNOWN FOR
CG-100
The CG-100, by Colospan Ltd., is an intraluminal bypass device protecting colorectal anastomoses, marking Eocene's shift to a GI-focused medtech and biopharmaceutical platform.
